Komori
TAUNS Laboratories (197A) · InitiativeAdvanced

Productivity Gains Through a New Core Business System and Medical Data Platform

First written in FY2025. 5 of 6 entries say "Advanced", first in 2026-05-14. Latest entry: FY2026.

6entries
2years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025Advanced2026-05-14 – FY20262025: 120252026: 52026
Same theme, other companies
Revamping the Operational Infrastructure Through the Use of ERP and ITA theme 20 companies write about · 0 as a headwind · 20 as a tailwind

The whole theme swung hardest in 2021: 2 of 6 companies on the "Worse" side.

8 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 20 companies compared. The sentences above are computed from all 20.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Total capital expenditures for the fiscal year were ¥4,480.450 million. Major items included ¥2,899.931 million for the plant building and ¥1,235.283 million for production equipment and other assets associated with construction of the Mt. Fuji Mishima Plant, as well as ¥163.125 million for the ERP system.」

    For the development of a new core system and business data infrastructure, the company specifically disclosed capital expenditures for the ERP system, indicating that the implementation project had progressed to the investment and capitalization stage.
  3. FY2025First statedAnnual report

    「As part of the project to introduce a new core system, we are reviewing our operating structure, standardizing various business data, and organizing master data to eliminate inefficient internal operations and improve operational efficiency and productivity. We are also developing an information platform to use various healthcare data in research and development.」

    The company has newly identified as a standalone issue a productivity initiative combining the introduction of an ERP and new core system, standardization of business data, and use of healthcare data in R&D.
Moved together

"IP and Technology Partnership Investments Toward the 10-Year Business Vision" moved the same way as this thread, in the same document, in 3 of its 6 moves.

333222★123456
  1. ★This thread
  2. 1IP and Technology Partnership Investments Toward the 10-Year Business Vision3×
  3. 2Expansion of Sales Channels Through Collaboration with Sales Representatives, Agencies and Pharmaceutical Companies3×
  4. 3Stable, Sustained Dividends Based on a Payout Ratio of Approximately 30%3×
  5. 4High-sensitivity, multi-analyte, quantitative POCT enabled by D-IA2×
  6. 5Development of New Core Technologies and an Inspection Platform2×
  7. 6Expansion into non-infectious disease areas, including chronic diseases, cancer and kidney disease2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for TAUNS Laboratories yet. It last moved in the Earnings presentation of 2026-08-13: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Productivity Gains Through a New Core Business System and Medical Data Platform | TAUNS Laboratories,Inc. (197A) | Komori